James Levin

Company: Cidara Therapeutics

Job title: Senior Director of Preclinical Development

Seminars:

Cidara Drug-Fc-Conjugates (Dfcs): A New Approach To Treatment Of Cancer 9:30 am

Cidara has developed a Drug-Fc-Conjugate (DFC) platform and is using it to advance candidates against several immuno-oncology targets.  We are advancing a development candidate DFC, CD421, that targets CD73. The emerging CD421 preclinical data package highlights its potential for differentiation from existing small molecule and monoclonal antibody therapies in clinical trials. CD421 combines the best…Read more

day: Day Two